Cargando…
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate
OTX2 is a potent oncogene that promotes tumor growth in Group 3 medulloblastoma. However, the mechanisms by which OTX2 represses neural differentiation are not well characterized. Here, we perform extensive multiomic analyses to identify an OTX2 regulatory network that controls Group 3 medulloblasto...
Autores principales: | Zagozewski, Jamie, Shahriary, Ghazaleh M., Morrison, Ludivine Coudière, Saulnier, Olivier, Stromecki, Margaret, Fresnoza, Agnes, Palidwor, Gareth, Porter, Christopher J., Forget, Antoine, Ayrault, Olivier, Hawkins, Cynthia, Chan, Jennifer A., Vladoiu, Maria C., Sundaresan, Lakshmikirupa, Arsenio, Janilyn, Taylor, Michael D., Ramaswamy, Vijay, Werbowetski-Ogilvie, Tamra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371715/ https://www.ncbi.nlm.nih.gov/pubmed/32686664 http://dx.doi.org/10.1038/s41467-020-17357-4 |
Ejemplares similares
-
Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
por: Stromecki, Margaret, et al.
Publicado: (2018) -
OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells
por: Kaur, Ravinder, et al.
Publicado: (2015) -
MDB-21. THE OTX2-REGULATED ALTERNATIVE SPLICING LANDSCAPE CONTROLS DIFFERENTIATION AND RECONSTITUTES THE DEVELOPMENTAL ORIGINS OF GROUP 3 MEDULLOBLASTOMA
por: Saulnier, Olivier, et al.
Publicado: (2023) -
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
por: Zagozewski, Jamie, et al.
Publicado: (2022) -
Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma
por: Martell, Emma, et al.
Publicado: (2023)